Lasmiditan Increases Odds of Freedom From Migraine Attacks
Lasmiditan is associated with greater odds of achieving pain freedom from migraine attacks compared with placebo.
Lasmiditan is associated with greater odds of achieving pain freedom from migraine attacks compared with placebo.
Patients who use opioids preoperatively may achieve improvements in outcomes after arthroscopic shoulder surgery, but opioid use may negatively affect satisfaction levels.
Financial incentives improved X-waiver training completion and buprenorphine prescribing rates in emergency department physicians.
Despite conflicting evidence, a third of primary physicians do not perceive OUD medication to be more effective than nonmedication treatment.
The American Heart Association released interim guidance on resuscitation care in patients with known or suspected COVID-19.
Study evaluated data related to cardiovascular events in patients with episodic or chronic migraine from 3 phase 3 studies of galcanezumab.
Interdisciplinary pain management programs incorporate physical and occupational therapy, pain psychology, medication management, and biofeedback.